<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Beta blocker,Beta blockers,Major Drug Groups,Beta blockers,Major Drug Groups,2004,2006,ACE inhibitor,ATC code C07,Acebutolol,Action potential" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Beta blocker - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Beta blocker</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <p><b>Beta blockers</b> (sometimes written as <b>β-blockers</b>) are a class of <a href="../../../m/e/d/Medication.html" title="Medication">drugs</a> used for various indications, but particularly for the management of <a href="../../../c/a/r/Cardiac_arrhythmia.html" title="Cardiac arrhythmia">cardiac arrhythmias</a> and cardioprotection after <a href="../../../m/y/o/Myocardial_infarction.html" title="Myocardial infarction">myocardial infarction</a>. Whilst once first-line treatment for <a href="../../../h/y/p/Hypertension.html" title="Hypertension">hypertension</a>, their role was downgraded in June 2006 in the <a href="../../../u/n/i/United_Kingdom_5ad7.html" title="United Kingdom">United Kingdom</a> to fourth-line as they perform less well than other drugs, particularly in the elderly, and there is increasing evidence that the most frequently used beta-blockers at usual doses carry an unacceptable risk of provoking <a href="../../../d/i/a/Diabetes_mellitus_type_2.html" title="Diabetes mellitus type 2">type 2 diabetes</a>.<sup id="_ref-0" class="reference"><a href="#_note-0" title="">[1]</a></sup></p>
<p>Beta blockers may also be referred to as <b>beta-adrenergic blocking agents</b>, <b>beta-adrenergic antagonists</b>, or <b>beta antagonists</b>.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Pharmacology"><span class="tocnumber">1</span> <span class="toctext">Pharmacology</span></a>
<ul>
<li class="toclevel-2"><a href="#.CE.B2-Receptor_antagonism"><span class="tocnumber">1.1</span> <span class="toctext">β-Receptor antagonism</span></a></li>
<li class="toclevel-2"><a href="#Intrinsic_sympathomimetic_activity"><span class="tocnumber">1.2</span> <span class="toctext">Intrinsic sympathomimetic activity</span></a></li>
<li class="toclevel-2"><a href="#.CE.B11-Receptor_antagonism"><span class="tocnumber">1.3</span> <span class="toctext">α1-Receptor antagonism</span></a></li>
<li class="toclevel-2"><a href="#Other_effects"><span class="tocnumber">1.4</span> <span class="toctext">Other effects</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Clinical_use"><span class="tocnumber">2</span> <span class="toctext">Clinical use</span></a>
<ul>
<li class="toclevel-2"><a href="#Congestive_heart_failure"><span class="tocnumber">2.1</span> <span class="toctext">Congestive heart failure</span></a></li>
<li class="toclevel-2"><a href="#Anxiety_and_performance_enhancement"><span class="tocnumber">2.2</span> <span class="toctext">Anxiety and performance enhancement</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Adverse_effects"><span class="tocnumber">3</span> <span class="toctext">Adverse effects</span></a></li>
<li class="toclevel-1"><a href="#Examples_of_beta_blockers"><span class="tocnumber">4</span> <span class="toctext">Examples of beta blockers</span></a>
<ul>
<li class="toclevel-2"><a href="#Historical"><span class="tocnumber">4.1</span> <span class="toctext">Historical</span></a></li>
<li class="toclevel-2"><a href="#Non-selective_agents"><span class="tocnumber">4.2</span> <span class="toctext">Non-selective agents</span></a></li>
<li class="toclevel-2"><a href="#.CE.B21-Selective_agents"><span class="tocnumber">4.3</span> <span class="toctext">β1-Selective agents</span></a></li>
<li class="toclevel-2"><a href="#Mixed_.CE.B11.2F.CE.B2-adrenergic_antagonists"><span class="tocnumber">4.4</span> <span class="toctext">Mixed α1/β-adrenergic antagonists</span></a></li>
<li class="toclevel-2"><a href="#.CE.B22-Selective_agents"><span class="tocnumber">4.5</span> <span class="toctext">β2-Selective agents</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Comparative_information"><span class="tocnumber">5</span> <span class="toctext">Comparative information</span></a>
<ul>
<li class="toclevel-2"><a href="#Pharmacological_differences"><span class="tocnumber">5.1</span> <span class="toctext">Pharmacological differences</span></a></li>
<li class="toclevel-2"><a href="#Indication_differences"><span class="tocnumber">5.2</span> <span class="toctext">Indication differences</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">6</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#Footnotes"><span class="tocnumber">7</span> <span class="toctext">Footnotes</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">8</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="Pharmacology" id="Pharmacology"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: Pharmacology">edit</a>]</span> <span class="mw-headline">Pharmacology</span></h2>
<p>Beta blockers block the action of <a href="../../../e/n/d/Endogenous.html" title="Endogenous">endogenous</a> <a href="../../../c/a/t/Catecholamine.html" title="Catecholamine">catecholamines</a> (<a href="../../../e/p/i/Epinephrine.html" title="Epinephrine">epinephrine</a> (adrenaline) and <a href="../../../n/o/r/Norepinephrine.html" title="Norepinephrine">norepinephrine</a> (noradrenaline) in particular), on β-<a href="../../../a/d/r/Adrenergic_receptor.html" title="Adrenergic receptor">adrenergic receptors</a>, part of the <a href="../../../s/y/m/Sympathetic_nervous_system.html" title="Sympathetic nervous system">sympathetic nervous system</a> which mediates the "<a href="../../../f/i/g/Fight_or_flight.html" title="Fight or flight">fight or flight</a>" response.</p>
<p>There are three known types of beta receptor, designated β<sub>1</sub>, β<sub>2</sub> and β<sub>3</sub>. β<sub>1</sub>-Adrenergic receptors are located mainly in the heart. β<sub>2</sub>-Adrenergic receptors are located mainly in the lungs, gastrointestinal tract, liver, uterus, vascular smooth muscle, and skeletal muscle. β<sub>3</sub>-receptors are located in fat cells.</p>
<p><a name=".CE.B2-Receptor_antagonism"></a></p>
<h3><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: β-Receptor antagonism">edit</a>]</span> <span class="mw-headline">β-Receptor antagonism</span></h3>
<p>Stimulation of β<sub>1</sub> receptors by epinephrine induces a positive <a href="../../../c/h/r/Chronotropic.html" title="Chronotropic">chronotropic</a> and <a href="../../../i/n/o/Inotropic.html" title="Inotropic">inotropic</a> effect on the heart and increases cardiac conduction velocity and automaticity. Stimulation of β<sub>2</sub> receptors induces <a href="../../../s/m/o/Smooth_muscle.html" title="Smooth muscle">smooth muscle</a> relaxation (resulting in <a href="../../../v/a/s/Vasodilation.html" title="Vasodilation">vasodilation</a> and <a href="../../../b/r/o/Bronchodilation.html" title="Bronchodilation">bronchodilation</a> amongst other actions), induces tremor in <a href="../../../s/k/e/Skeletal_muscle.html" title="Skeletal muscle">skeletal muscle</a>, and increases <a href="../../../g/l/y/Glycogenolysis.html" title="Glycogenolysis">glycogenolysis</a> in the <a href="../../../l/i/v/Liver.html" title="Liver">liver</a> and <a href="../../../s/k/e/Skeletal_muscle.html" title="Skeletal muscle">skeletal muscle</a>. Stimulation of β<sub>3</sub> receptors induces <a href="../../../l/i/p/Lipolysis.html" title="Lipolysis">lipolysis</a>.</p>
<p>Beta blockers inhibit these normal epinephrine-mediated <a href="../../../s/y/m/Sympathetic_nervous_system.html" title="Sympathetic nervous system">sympathetic</a> actions, but have minimal effect on resting subjects. That is, they reduce the effect of excitement/physical exertion on heart rate and force of contraction, dilation of blood vessels, opening of bronchi, reduce tremor, and breakdown of <a href="../../../g/l/y/Glycogen.html" title="Glycogen">glycogen</a>..</p>
<p>It is therefore somewhat unexpected that non-selective beta blockers have an <a href="../../../a/n/t/Antihypertensive.html" title="Antihypertensive">antihypertensive</a> effect, since they appear to cause <a href="../../../v/a/s/Vasoconstriction.html" title="Vasoconstriction">vasoconstriction</a>. The antihypertensive mechanism appears to involve: reduction in cardiac output (due to negative chronotropic and inotropic effects), reduction in <a href="../../../r/e/n/Renin.html" title="Renin">renin</a> release from the kidneys, and a <a href="../../../c/e/n/Central_nervous_system.html" title="Central nervous system">central nervous system</a> effect to reduce <a href="../../../s/y/m/Sympathetic_nervous_system.html" title="Sympathetic nervous system">sympathetic</a> activity.</p>
<p>Antianginal effects result from negative <a href="../../../c/h/r/Chronotropic.html" title="Chronotropic">chronotropic</a> and <a href="../../../i/n/o/Inotropic.html" title="Inotropic">inotropic</a> effects, which decrease cardiac workload and oxygen demand.</p>
<p>The antiarrhythmic effects of beta blockers arise from sympathetic nervous system blockade – resulting in depression of <a href="../../../s/i/n/Sinus_node.html" title="Sinus node">sinus node</a> function and <a href="../../../a/t/r/Atrioventricular_node.html" title="Atrioventricular node">atrioventricular node</a> conduction, and prolonged <a href="../../../a/t/r/Atrium_%28anatomy%29.html" title="Atrium (anatomy)">atrial</a> <a href="../../../r/e/f/Refractory_period_%28cardiac%29.html" title="Refractory period (cardiac)">refractory periods</a>. <a href="../../../s/o/t/Sotalol.html" title="Sotalol">Sotalol</a>, in particular, has additional antiarrhythmic properties and prolongs <a href="../../../a/c/t/Action_potential.html" title="Action potential">action potential</a> duration through <a href="../../../p/o/t/Potassium_channel.html" title="Potassium channel">potassium channel</a> blockade.</p>
<p><a name="Intrinsic_sympathomimetic_activity" id="Intrinsic_sympathomimetic_activity"></a></p>
<h3><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: Intrinsic sympathomimetic activity">edit</a>]</span> <span class="mw-headline">Intrinsic sympathomimetic activity</span></h3>
<p>Some beta blockers (e.g. <a href="../../../o/x/p/Oxprenolol.html" title="Oxprenolol">oxprenolol</a> and <a href="../../../p/i/n/Pindolol.html" title="Pindolol">pindolol</a>) exhibit intrinsic sympathomimetic activity (ISA). These agents are capable of exerting low level <a href="../../../r/e/c/Receptor_agonist.html" title="Receptor agonist">agonist</a> activity at the β-adrenergic receptor while simultaneously acting as a receptor site <a href="../../../r/e/c/Receptor_antagonist.html" title="Receptor antagonist">antagonist</a>. These agents, therefore, may be useful in individuals exhibiting excessive <a href="../../../b/r/a/Bradycardia.html" title="Bradycardia">bradycardia</a> with sustained beta blocker therapy.</p>
<p>Agents with ISA are not used post-<a href="../../../m/y/o/Myocardial_infarction.html" title="Myocardial infarction">myocardial infarction</a> as they have not been demonstrated to be beneficial. They may also be less effective than other beta blockers in the management of <a href="../../../a/n/g/Angina.html" title="Angina">angina</a> and <a href="../../../t/a/c/Tachyarrhythmia.html" title="Tachyarrhythmia">tachyarrhythmia</a> (Rossi, 2006).</p>
<p><a name=".CE.B11-Receptor_antagonism"></a></p>
<h3><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: α1-Receptor antagonism">edit</a>]</span> <span class="mw-headline">α<sub>1</sub>-Receptor antagonism</span></h3>
<p>Some beta blockers (e.g. <a href="../../../l/a/b/Labetalol.html" title="Labetalol">labetalol</a> and <a href="../../../c/a/r/Carvedilol.html" title="Carvedilol">carvedilol</a>) exhibit mixed antagonism of both β- and α<sub>1</sub>-adrenergic receptors, which provides additional <a href="../../../a/r/t/Arteriole.html" title="Arteriole">arteriolar</a> vasodilating action.</p>
<p><a name="Other_effects" id="Other_effects"></a></p>
<h3><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: Other effects">edit</a>]</span> <span class="mw-headline">Other effects</span></h3>
<p>Beta blockers decrease nocturnal <a href="../../../m/e/l/Melatonin.html" title="Melatonin">melatonin</a> release, perhaps partly accounting for sleep disturbance caused by some agents (Stoschitzky et al., 1999).</p>
<p><a name="Clinical_use" id="Clinical_use"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: Clinical use">edit</a>]</span> <span class="mw-headline">Clinical use</span></h2>
<p>Large differences exist in the pharmacology of agents within the class, thus not all beta blockers are used for all indications listed below.</p>
<p>Indications for beta blockers include:</p>
<ul>
<li><a href="../../../h/y/p/Hypertension.html" title="Hypertension">Hypertension</a></li>
<li><a href="../../../a/n/g/Angina.html" title="Angina">Angina</a></li>
<li>Mitral Valve Prolapse</li>
<li><a href="../../../c/a/r/Cardiac_arrhythmia.html" title="Cardiac arrhythmia">Cardiac arrhythmia</a></li>
<li><a href="../../../c/o/n/Congestive_heart_failure.html" title="Congestive heart failure">Congestive heart failure</a></li>
<li><a href="../../../m/y/o/Myocardial_infarction.html" title="Myocardial infarction">Myocardial infarction</a></li>
<li><a href="../../../g/l/a/Glaucoma.html" title="Glaucoma">Glaucoma</a></li>
<li><a href="../../../m/i/g/Migraine.html" title="Migraine">Migraine</a> <a href="../../../p/r/o/Prophylaxis.html" title="Prophylaxis">prophylaxis</a></li>
<li>Symptomatic control (<a href="../../../t/a/c/Tachycardia.html" title="Tachycardia">tachycardia</a>, <a href="../../../t/r/e/Tremor.html" title="Tremor">tremor</a>) in <a href="../../../a/n/x/Anxiety.html" title="Anxiety">anxiety</a> and <a href="../../../h/y/p/Hyperthyroidism.html" title="Hyperthyroidism">hyperthyroidism</a></li>
<li><a href="../../../e/s/s/Essential_tremor.html" title="Essential tremor">Essential tremor</a></li>
<li><a href="../../../p/h/a/Phaeochromocytoma.html" title="Phaeochromocytoma">Phaeochromocytoma</a>, in conjunction with <a href="../../../a/l/p/Alpha_blocker.html" title="Alpha blocker">α-blocker</a></li>
</ul>
<p>Beta blockers have also been used in the following conditions:</p>
<ul>
<li>Hypertrophic obstructive <a href="../../../c/a/r/Cardiomyopathy.html" title="Cardiomyopathy">cardiomyopathy</a></li>
<li>Acute dissecting <a href="../../../a/o/r/Aortic_aneurysm.html" title="Aortic aneurysm">aortic aneurysm</a></li>
<li><a href="../../../m/a/r/Marfan_syndrome.html" title="Marfan syndrome">Marfan syndrome</a> (chronic treatment with propranolol slows progression of aortic dilation and its complications)</li>
<li>Prevention of variceal bleeding in <a href="../../../p/o/r/Portal_hypertension.html" title="Portal hypertension">portal hypertension</a></li>
<li>Possible mitigation of <a href="../../../h/y/p/Hyperhidrosis.html" title="Hyperhidrosis">hyperhidrosis</a></li>
</ul>
<p><a name="Congestive_heart_failure" id="Congestive_heart_failure"></a></p>
<h3><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: Congestive heart failure">edit</a>]</span> <span class="mw-headline">Congestive heart failure</span></h3>
<p>Although beta blockers were once contraindicated in <a href="../../../c/o/n/Congestive_heart_failure.html" title="Congestive heart failure">congestive heart failure</a>, as they have the potential to worsen the condition, studies in the late 1990s showed their positive effects on morbidity and mortality in congestive heart failure (Hjalmarson, 2000; Leizorovicz, 2002; Packer, 2002). <a href="../../../b/i/s/Bisoprolol.html" title="Bisoprolol">Bisoprolol</a>, <a href="../../../c/a/r/Carvedilol.html" title="Carvedilol">carvedilol</a> and sustained-release <a href="../../../m/e/t/Metoprolol.html" title="Metoprolol">metoprolol</a> are specifically indicated as adjuncts to standard <a href="../../../a/c/e/ACE_inhibitor_fd43.html" title="ACE inhibitor">ACE inhibitor</a> and <a href="../../../d/i/u/Diuretic.html" title="Diuretic">diuretic</a> therapy in congestive heart failure.</p>
<p><a name="Anxiety_and_performance_enhancement" id="Anxiety_and_performance_enhancement"></a></p>
<h3><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: Anxiety and performance enhancement">edit</a>]</span> <span class="mw-headline">Anxiety and performance enhancement</span></h3>
<p>Some people, particularly <a href="../../../m/u/s/Musicians.html" title="Musicians">musicians</a>, use beta blockers to avoid <a href="../../../g/l/o/Glossophobia.html" title="Glossophobia">stage fright</a> and tremor during public performance and <a href="../../../a/u/d/Audition.html" title="Audition">auditions</a>. The physiological symptoms of the fight/flight response associated with <a href="../../../p/e/r/Performance_anxiety.html" title="Performance anxiety">performance anxiety</a> and <a href="../../../p/a/n/Panic.html" title="Panic">panic</a> (pounding heart, cold/clammy hands, increased respiration, sweating, etc.) are significantly reduced, thus enabling anxious individuals to concentrate on the task at hand.</p>
<p>Currently, no beta blocker is approved for <a href="../../../a/n/x/Anxiolytic.html" title="Anxiolytic">anxiolytic</a> use by the US FDA. Still, use of beta blockers to combat the physical symptoms of <a href="../../../a/n/x/Anxiety.html" title="Anxiety">anxiety</a> is not uncommon, particularly among performers, and there are studies which confirm their efficacy as anxiolytics. (Schneier 2006)</p>
<p>Since they lower heart rate and reduce tremor, beta blockers have been used by some <a href="../../../o/l/y/Olympic_Games_4ea8.html" title="Olympic Games">Olympic</a> <a href="../../../m/a/r/Marksman.html" title="Marksman">marksmen</a> to enhance performance, though beta blockers are banned by the <a href="../../../i/n/t/International_Olympic_Committee_e5dd.html" title="International Olympic Committee">International Olympic Committee</a> (IOC).<sup id="_ref-1" class="reference"><a href="#_note-1" title="">[2]</a></sup></p>
<p><a name="Adverse_effects" id="Adverse_effects"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: Adverse effects">edit</a>]</span> <span class="mw-headline">Adverse effects</span></h2>
<p><a href="../../../a/d/v/Adverse_drug_reaction.html" title="Adverse drug reaction">Adverse drug reactions</a> (ADRs) associated with the use of beta blockers include: nausea, diarrhoea, <a href="../../../b/r/o/Bronchospasm.html" title="Bronchospasm">bronchospasm</a>, <a href="../../../d/y/s/Dyspnoea.html" title="Dyspnoea">dyspnoea</a>, cold extremities, exacerbation of <a href="../../../r/a/y/Raynaud%27s_syndrome.html" title="Raynaud's syndrome">Raynaud's syndrome</a>, <a href="../../../b/r/a/Bradycardia.html" title="Bradycardia">bradycardia</a>, <a href="../../../h/y/p/Hypotension.html" title="Hypotension">hypotension</a>, <a href="../../../h/e/a/Heart_failure.html" title="Heart failure">heart failure</a>, <a href="../../../h/e/a/Heart_block.html" title="Heart block">heart block</a>, fatigue, dizziness, abnormal vision, decreased concentration, hallucinations, <a href="../../../i/n/s/Insomnia.html" title="Insomnia">insomnia</a>, nightmares, depression, <a href="../../../s/e/x/Sexual_dysfunction.html" title="Sexual dysfunction">sexual dysfunction</a>, <a href="../../../e/r/e/Erectile_dysfunction.html" title="Erectile dysfunction">erectile dysfunction</a> and/or alteration of glucose and lipid metabolism. Mixed α<sub>1</sub>/β-antagonist therapy is also commonly associated with <a href="../../../o/r/t/Orthostatic_hypotension.html" title="Orthostatic hypotension">orthostatic hypotension</a>. Carvedilol therapy is commonly associated with <a href="../../../o/e/d/Oedema.html" title="Oedema">oedema</a>. (Rossi, 2006)</p>
<p><a href="../../../c/e/n/Central_nervous_system.html" title="Central nervous system">Central nervous system</a> (CNS) adverse effects (hallucinations, insomnia, nightmares, depression) are more common in agents with greater lipid solubility, which are able to cross the <a href="../../../b/l/o/Blood-brain_barrier.html" title="Blood-brain barrier">blood-brain barrier</a> into the CNS. Similarly, CNS adverse effects are less common in agents with greater aqueous solubility (listed below).</p>
<p>Adverse effects associated with β<sub>2</sub>-adrenergic receptor antagonist activity (bronchospasm, peripheral vasoconstriction, alteration of glucose and lipid metabolism) are less common with β<sub>1</sub>-selective (often termed "cardioselective") agents, however receptor selectivity diminishes at higher doses.</p>
<p>A 2007 study (W.J. Elliott, P. Meyer, The Lancet, Jan 20, 2007) revealed that diuretics and beta-blockers used for hypertension increase a patient's risk of developing diabetes. ACE inhibitors and Angiotension Receptor Blockers (ARBs) actually decrease the risk of diabetes. Clinical guidelines in Great Britain, but not in the United States, call for avoiding diuretics and beta-blockers as first-line treatment of hypertension due to the risk of diabetes.</p>
<p><a name="Examples_of_beta_blockers" id="Examples_of_beta_blockers"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: Examples of beta blockers">edit</a>]</span> <span class="mw-headline">Examples of beta blockers</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:202px;"><a href="../../../d/i/c/Image%7EDichloroisoprenaline.png_5d74.html" class="internal" title="Dichloroisoprenaline, the first beta blocker."><img src="../../../upload/thumb/6/6f/Dichloroisoprenaline.png/200px-Dichloroisoprenaline.png" alt="Dichloroisoprenaline, the first beta blocker." width="200" height="90" longdesc="../../../d/i/c/Image%7EDichloroisoprenaline.png_5d74.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../d/i/c/Image%7EDichloroisoprenaline.png_5d74.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Dichloroisoprenaline, the first beta blocker.</div>
</div>
</div>
<p><a name="Historical" id="Historical"></a></p>
<h3><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: Historical">edit</a>]</span> <span class="mw-headline">Historical</span></h3>
<ul>
<li><a href="../../../d/i/c/Dichloroisoprenaline.html" title="Dichloroisoprenaline">Dichloroisoprenaline</a></li>
<li><a href="../../../p/r/a/Practolol.html" title="Practolol">Practolol</a></li>
<li>Pronethaolol</li>
</ul>
<p><a name="Non-selective_agents" id="Non-selective_agents"></a></p>
<h3><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: Non-selective agents">edit</a>]</span> <span class="mw-headline">Non-selective agents</span></h3>
<ul>
<li>Alprenolol</li>
<li><a href="../../../c/a/r/Carteolol.html" title="Carteolol">Carteolol</a></li>
<li><a href="../../../l/e/v/Levobunolol.html" title="Levobunolol">Levobunolol</a></li>
<li>Mepindolol</li>
<li><a href="../../../m/e/t/Metipranolol.html" title="Metipranolol">Metipranolol</a></li>
<li><a href="../../../n/a/d/Nadolol.html" title="Nadolol">Nadolol</a></li>
<li><a href="../../../o/x/p/Oxprenolol.html" title="Oxprenolol">Oxprenolol</a></li>
<li><a href="../../../p/e/n/Penbutolol.html" title="Penbutolol">Penbutolol</a></li>
<li><a href="../../../p/i/n/Pindolol.html" title="Pindolol">Pindolol</a></li>
<li><a href="../../../p/r/o/Propranolol.html" title="Propranolol">Propranolol</a></li>
<li><a href="../../../s/o/t/Sotalol.html" title="Sotalol">Sotalol</a></li>
<li><a href="../../../t/i/m/Timolol.html" title="Timolol">Timolol</a></li>
</ul>
<p><a name=".CE.B21-Selective_agents"></a></p>
<h3><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: β1-Selective agents">edit</a>]</span> <span class="mw-headline">β<sub>1</sub>-Selective agents</span></h3>
<ul>
<li><a href="../../../a/c/e/Acebutolol.html" title="Acebutolol">Acebutolol</a></li>
<li><a href="../../../a/t/e/Atenolol.html" title="Atenolol">Atenolol</a></li>
<li><a href="../../../b/e/t/Betaxolol.html" title="Betaxolol">Betaxolol</a></li>
<li><a href="../../../b/i/s/Bisoprolol.html" title="Bisoprolol">Bisoprolol</a></li>
<li><a href="../../../e/s/m/Esmolol.html" title="Esmolol">Esmolol</a></li>
<li><a href="../../../m/e/t/Metoprolol.html" title="Metoprolol">Metoprolol</a></li>
<li><a href="../../../n/e/b/Nebivolol.html" title="Nebivolol">Nebivolol</a></li>
</ul>
<p><a name="Mixed_.CE.B11.2F.CE.B2-adrenergic_antagonists" id="Mixed_.CE.B11.2F.CE.B2-adrenergic_antagonists"></a></p>
<h3><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: Mixed α1/β-adrenergic antagonists">edit</a>]</span> <span class="mw-headline">Mixed α<sub>1</sub>/β-adrenergic antagonists</span></h3>
<ul>
<li><a href="../../../c/a/r/Carvedilol.html" title="Carvedilol">Carvedilol</a></li>
<li>Celiprolol</li>
<li><a href="../../../l/a/b/Labetalol.html" title="Labetalol">Labetalol</a></li>
</ul>
<p><a name=".CE.B22-Selective_agents"></a></p>
<h3><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: β2-Selective agents">edit</a>]</span> <span class="mw-headline">β<sub>2</sub>-Selective agents</span></h3>
<ul>
<li><a href="../../../b/u/t/Butoxamine.html" title="Butoxamine">Butoxamine</a> (weak α-adrenergic agonist activity)</li>
</ul>
<p><a name="Comparative_information" id="Comparative_information"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: Comparative information">edit</a>]</span> <span class="mw-headline">Comparative information</span></h2>
<p><a name="Pharmacological_differences" id="Pharmacological_differences"></a></p>
<h3><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: Pharmacological differences">edit</a>]</span> <span class="mw-headline">Pharmacological differences</span></h3>
<ul>
<li>Agents with intrinsic sympathomimetic action (ISA)
<ul>
<li>Acebutolol, carteolol, celiprolol, mepindolol, oxprenolol, pindolol</li>
</ul>
</li>
<li>Agents with greater aqueous solubility
<ul>
<li>Atenolol, celiprolol, nadolol, sotalol</li>
</ul>
</li>
<li>Agents with membrane stabilising activity
<ul>
<li>Acebutolol, betaxolol, pindolol, propranolol</li>
</ul>
</li>
<li>Agents with <a href="../../../a/n/t/Antioxidant.html" title="Antioxidant">antioxidant</a> effect
<ul>
<li>Carvedilol</li>
</ul>
</li>
</ul>
<p><a name="Indication_differences" id="Indication_differences"></a></p>
<h3><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: Indication differences">edit</a>]</span> <span class="mw-headline">Indication differences</span></h3>
<ul>
<li>Agents specifically indicated for <a href="../../../c/a/r/Cardiac_arrhythmia.html" title="Cardiac arrhythmia">cardiac arrhythmia</a>
<ul>
<li>Esmolol, sotalol</li>
</ul>
</li>
<li>Agents specifically indicated for <a href="../../../c/o/n/Congestive_heart_failure.html" title="Congestive heart failure">congestive heart failure</a>
<ul>
<li>Bisoprolol, carvedilol, sustained-release metoprolol</li>
</ul>
</li>
<li>Agents specifically indicated for <a href="../../../g/l/a/Glaucoma.html" title="Glaucoma">glaucoma</a>
<ul>
<li>Betaxolol, carteolol, levobunolol, metipranolol, timolol</li>
</ul>
</li>
<li>Agents specifically indicated for <a href="../../../m/y/o/Myocardial_infarction.html" title="Myocardial infarction">myocardial infarction</a>
<ul>
<li>Atenolol, metoprolol, propranolol</li>
</ul>
</li>
<li>Agents specifically indicated for <a href="../../../m/i/g/Migraine.html" title="Migraine">migraine</a> prophylaxis
<ul>
<li>Timolol, propranolol</li>
</ul>
</li>
</ul>
<p>Propranolol is the only agent indicated for control of tremor, <a href="../../../p/o/r/Portal_hypertension.html" title="Portal hypertension">portal hypertension</a> and oesophageal variceal bleeding, and used in conjunction with α-blocker therapy in <a href="../../../p/h/a/Phaeochromocytoma.html" title="Phaeochromocytoma">phaeochromocytoma</a> (Rossi, 2006).</p>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<ul>
<li>Hjalmarson A, Goldstein S, Fagerberg B, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA. 2000;283(10):1295-302. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10714728" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10714728">PMID 10714728</a></li>
<li>Leizorovicz A, Lechat P, Cucherat M, Bugnard F. Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies – CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol Study. Am Heart J. 2002;143(2):301-7. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11835035" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11835035">PMID 11835035</a></li>
<li>Packer M, Fowler MB, Roecker EB, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 2002;106(17):2194-9. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12390947" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12390947">PMID 12390947</a></li>
<li>Rossi S, editor. <a href="../../../a/u/s/Australian_Medicines_Handbook_0c4c.html" title="Australian Medicines Handbook">Australian Medicines Handbook</a> 2006. Adelaide: Australian Medicines Handbook; 2006.</li>
<li>Stoschitzky K, Sakotnik A, Lercher P, Zweiker R, Maier R, Liebmann P, Lindner W. Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol. 1999 Apr;55(2):111-5. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10335905" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10335905">PMID 10335905</a></li>
<li>Schneier FR. <i>Clinical practice. Social anxiety disorder.</i> N Engl J Med. 2006 Sep 7;355(10):1029-36. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16957148" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16957148">PMID 16957148</a>.</li>
<li>Katzung BG. Basic and Clinical Pharmacology. 9th edition. Lange Medical Books/McGraw-Hill Medical Publishing Division. New York, New York, 2004. Page 130, table 9-3. ISBN: 0-07-144097-6</li>
</ul>
<p><a name="Footnotes" id="Footnotes"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: Footnotes">edit</a>]</span> <span class="mw-headline">Footnotes</span></h2>
<ol class="references">
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> Sheetal Ladva (28/06/2006). <a href="http://www.nelm.nhs.uk/Record%20Viewing/viewRecord.aspx?id=567178" class="external text" title="http://www.nelm.nhs.uk/Record%20Viewing/viewRecord.aspx?id=567178" rel="nofollow">NICE and BHS launch updated hypertension guideline</a>. <a href="../../../n/a/t/National_Institute_for_Health_and_Clinical_Excellence_6317.html" title="National Institute for Health and Clinical Excellence">National Institute for Health and Clinical Excellence</a>. Retrieved on <a href="../../../2/0/0/2006.html" title="2006">2006</a>-<a href="../../../s/e/p/September_30.html" title="September 30">09-30</a>.</li>
<li id="_note-1"><b><a href="#_ref-1" title="">^</a></b> World Anti-Doping Agency (19/09/2005). <a href="http://multimedia.olympic.org/pdf/en_report_1037.pdf" class="external text" title="http://multimedia.olympic.org/pdf/en_report_1037.pdf" rel="nofollow">The World Anti-Doping Code: The 2006 Prohibited List International Standard</a>. <a href="../../../w/o/r/World_Anti-Doping_Agency_42d6.html" title="World Anti-Doping Agency">World Anti-Doping Agency</a>. Retrieved on <a href="../../../2/0/0/2006.html" title="2006">2006</a>-<a href="../../../d/e/c/December_13.html" title="December 13">12-13</a>.</li>
</ol>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../b/e/t/Beta_blocker.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.sfgate.com/cgi-bin/article.cgi?file=/c/a/2004/10/17/MNGB599PJC1.DTL" class="external text" title="http://www.sfgate.com/cgi-bin/article.cgi?file=/c/a/2004/10/17/MNGB599PJC1.DTL" rel="nofollow">Musicians using beta blockers</a></li>
<li><a href="http://www.nytimes.com/2004/10/17/arts/music/17tind.html?ex=1270785600&amp;en=37bef79604f97228&amp;ei=5090&amp;partner=rssuserland" class="external text" title="http://www.nytimes.com/2004/10/17/arts/music/17tind.html?ex=1270785600&amp;en=37bef79604f97228&amp;ei=5090&amp;partner=rssuserland" rel="nofollow">Better Playing Through Chemistry</a> by Blair Tindall, <i><a href="../../../n/e/w/New_York_Times_d49e.html" title="New York Times">New York Times</a></i>, <a href="../../../o/c/t/October_17.html" title="October 17">October 17</a>, <a href="../../../2/0/0/2004.html" title="2004">2004</a>. (Discussing the use of beta-blockers among professional musicians.)</li>
</ul>
<table class="navbox collapsible" style="margin: auto;">
<tr>
<th colspan="2" style="text-align:center;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap; float:left;width:6em;text-align:left;"><a href="../../../b/e/t/Template%7EBeta_blockers_5115.html" title="Template:Beta blockers"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<span style="color: #002bb8;" title="Discussion about this template">d</span>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../b/e/t/Template%7EBeta_blockers_5115.html" class="external text" title="http://en.wikipedia.org../../../b/e/t/Template%7EBeta_blockers_5115.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
<strong class="selflink">Beta blockers</strong> <a href="../../../a/t/c/ATC_code_C07_0a08.html" title="ATC code C07">(C07)</a></th>
</tr>
<tr>
<th style="">Non-selective β antagonists (<a href="../../../a/t/c/ATC_code_C07_0a08.html#C07AA_Beta_blocking_agents.2C_non-selective" title="ATC code C07">C07AA</a>)</th>
<td><a href="../../../m/e/t/Metipranolol.html" title="Metipranolol">Metipranolol</a>, <a href="../../../n/a/d/Nadolol.html" title="Nadolol">Nadolol</a>, <a href="../../../o/x/p/Oxprenolol.html" title="Oxprenolol">Oxprenolol</a>, <a href="../../../p/e/n/Penbutolol.html" title="Penbutolol">Penbutolol</a>, <a href="../../../p/i/n/Pindolol.html" title="Pindolol">Pindolol</a>, <a href="../../../p/r/o/Propranolol.html" title="Propranolol">Propranolol</a>, <a href="../../../t/i/m/Timolol.html" title="Timolol">Timolol</a>, <a href="../../../s/o/t/Sotalol.html" title="Sotalol">Sotalol</a></td>
</tr>
<tr>
<th style="">β<sub>1</sub> antagonists (<i>cardioselective</i>) (<a href="../../../a/t/c/ATC_code_C07_0a08.html#C07AB_Beta_blocking_agents.2C_selective" title="ATC code C07">C07AB</a>)</th>
<td><a href="../../../a/t/e/Atenolol.html" title="Atenolol">Atenolol</a>, <a href="../../../a/c/e/Acebutolol.html" title="Acebutolol">Acebutolol</a>, <a href="../../../b/e/t/Betaxolol.html" title="Betaxolol">Betaxolol</a>, <a href="../../../b/i/s/Bisoprolol.html" title="Bisoprolol">Bisoprolol</a>, <a href="../../../e/s/m/Esmolol.html" title="Esmolol">Esmolol</a>, <a href="../../../m/e/t/Metoprolol.html" title="Metoprolol">Metoprolol</a>, <a href="../../../n/e/b/Nebivolol.html" title="Nebivolol">Nebivolol</a></td>
</tr>
<tr>
<th style="">Mixed α<sub>1</sub>/β antagonists (<a href="../../../a/t/c/ATC_code_C07_0a08.html#C07AG_Alpha_and_beta_blocking_agents" title="ATC code C07">C07AG</a>)</th>
<td><a href="../../../c/a/r/Carvedilol.html" title="Carvedilol">Carvedilol</a>, <a href="../../../l/a/b/Labetalol.html" title="Labetalol">Labetalol</a></td>
</tr>
</table>
<table class="navbox collapsible autocollapse" style="margin: auto; text-align:left">
<tr>
<th colspan="2" style="text-align:center;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap; float:left;width:6em;text-align:left;"><a href="../../../m/a/j/Template%7EMajor_Drug_Groups_2544.html" title="Template:Major Drug Groups"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="../../../m/a/j/Template_talk%7EMajor_Drug_Groups_149b.html" title="Template talk:Major Drug Groups"><span title="Discussion about this template">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../m/a/j/Template%7EMajor_Drug_Groups_2544.html" class="external text" title="http://en.wikipedia.org../../../m/a/j/Template%7EMajor_Drug_Groups_2544.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
Major Drug Groups</th>
</tr>
<tr>
<th style=""><a href="../../../b/r/a/Brain.html" title="Brain">Brain</a> and <a href="../../../n/e/r/Nervous_system.html" title="Nervous system">Nervous system</a></th>
<td><a href="../../../a/n/a/Analgesic.html" title="Analgesic">Analgesics</a>, <a href="../../../a/n/e/Anesthesia.html" title="Anesthesia">Anesthetics</a>, <a href="../../../a/n/x/Anxiolytic.html" title="Anxiolytic">Anxiolytics</a>, <a href="../../../a/n/t/Antidepressant.html" title="Antidepressant">Antidepressants</a>, <a href="../../../a/n/t/Antipsychotic.html" title="Antipsychotic">Antipsychotics</a>, <a href="../../../a/n/t/Anticonvulsant.html" title="Anticonvulsant">Anticonvulsants</a>, <a href="../../../s/t/i/Stimulant.html" title="Stimulant">Nervous system stimulants</a>, <a href="../../../a/n/t/Antiemetic.html" title="Antiemetic">Antiemetics</a>, <a href="../../../p/s/y/Psychedelics%2C_dissociatives_and_deliriants.html" title="Psychedelics, dissociatives and deliriants">Hallucinogens</a>, <a href="../../../m/o/o/Mood_stabilizer.html" title="Mood stabilizer">Mood stabilizers</a></td>
</tr>
<tr>
<th style=""><a href="../../../r/e/s/Respiratory_system.html" title="Respiratory system">Respiratory system</a></th>
<td><a href="../../../b/r/o/Bronchodilator.html" title="Bronchodilator">Bronchodilators</a>, <a href="../../../d/e/c/Decongestant.html" title="Decongestant">Decongestants</a></td>
</tr>
<tr>
<th style=""><a href="../../../h/e/a/Heart.html" title="Heart">Heart</a> and <a href="../../../c/i/r/Circulatory_system.html" title="Circulatory system">Circulation</a></th>
<td><a href="../../../a/c/e/ACE_inhibitor_fd43.html" title="ACE inhibitor">Angiotensin converting enzyme inhibitors</a>, <a href="../../../a/n/t/Antiarrhythmic_agent.html" title="Antiarrhythmic agent">Antiarrhythmics</a>, <a href="../../../a/n/t/Antianginal.html" title="Antianginal">Antianginals</a>, <a href="../../../a/n/t/Antihypertensive.html" title="Antihypertensive">Antihypertensives</a>, <a href="../../../h/y/p/Hypolipidemic_agent.html" title="Hypolipidemic agent">Antihyperlipidemics</a>, <a href="../../../a/n/t/Anticoagulant.html" title="Anticoagulant">Anticoagulants</a>, <a href="../../../a/n/t/Antiplatelet_drug.html" title="Antiplatelet drug">Antiplatelets</a>, <strong class="selflink">Beta blockers</strong>, <a href="../../../d/i/u/Diuretic.html" title="Diuretic">Diuretics</a>, <a href="../../../t/h/r/Thrombolytic_drug.html" title="Thrombolytic drug">Thrombolytics</a>, <a href="../../../v/a/s/Vasodilator.html" title="Vasodilator">Vasodilators</a></td>
</tr>
<tr>
<th style=""><a href="../../../g/a/s/Gastrointestinal_tract.html" title="Gastrointestinal tract">Gastrointestinal tract</a></th>
<td><a href="../../../a/n/t/Antacid.html" title="Antacid">Antacids</a>, <a href="../../../a/n/t/Antidiarrhoeal.html" title="Antidiarrhoeal">Antidiarrhoeals</a>, <a href="../../../h/2/-/H2-receptor_antagonist.html" title="H2-receptor antagonist">H2-receptor antagonists</a>, <a href="../../../p/r/o/Proton_pump_inhibitor.html" title="Proton pump inhibitor">Proton pump inhibitors</a>, <a href="../../../l/a/x/Laxative.html" title="Laxative">Laxatives</a></td>
</tr>
<tr>
<th style=""><a href="../../../m/u/s/Muscle.html" title="Muscle">Muscles</a>, <a href="../../../b/o/n/Bone.html" title="Bone">Bones</a>, and <a href="../../../j/o/i/Joint.html" title="Joint">Joints</a></th>
<td><a href="../../../a/n/t/Anti-inflammatory.html" title="Anti-inflammatory">Anti-inflammatories</a>, <a href="../../../d/i/s/Disease-modifying_antirheumatic_drug.html" title="Disease-modifying antirheumatic drug">Antirheumatics</a>, <a href="../../../c/o/r/Corticosteroid.html" title="Corticosteroid">Corticosteroids</a>, <a href="../../../m/u/s/Muscle_relaxant.html" title="Muscle relaxant">Muscle relaxants</a></td>
</tr>
<tr>
<th style=""><a href="../../../a/l/l/Allergy.html" title="Allergy">Allergy</a></th>
<td><a href="../../../a/n/t/Antihistamine.html" title="Antihistamine">Antihistamines</a></td>
</tr>
<tr>
<th style=""><a href="../../../i/n/f/Infection.html" title="Infection">Infections</a> and <a href="../../../i/n/f/Infestation.html" title="Infestation">Infestations</a></th>
<td><a href="../../../a/n/t/Antibiotic.html" title="Antibiotic">Antibiotics</a>, <a href="../../../a/n/t/Antiviral_drug.html" title="Antiviral drug">Antivirals</a>, <a href="../../../v/a/c/Vaccine.html" title="Vaccine">Vaccines</a>, <a href="../../../a/n/t/Antiprotozoal_agent.html" title="Antiprotozoal agent">Antiprotozoals</a>, <a href="../../../a/n/t/Antifungal_drug.html" title="Antifungal drug">Antifungals</a>, <a href="../../../a/n/t/Anthelmintic.html" title="Anthelmintic">Anthelmintics</a></td>
</tr>
<tr>
<th style=""><a href="../../../e/n/d/Endocrine_system.html" title="Endocrine system">Endocrine system</a></th>
<td><a href="../../../c/o/r/Corticosteroid.html" title="Corticosteroid">Corticosteroids</a>, <a href="../../../a/n/t/Anti-diabetic_drug.html" title="Anti-diabetic drug">Anti-diabetics</a></td>
</tr>
<tr>
<th style=""><a href="../../../m/a/l/Malignant.html" title="Malignant">Malignant</a> and <a href="../../../i/m/m/Immune_system.html" title="Immune system">Immune</a> disease</th>
<td><a href="../../../c/h/e/Chemotherapy.html" title="Chemotherapy">Anticancer agents</a>, <a href="../../../i/m/m/Immunosuppressive_drug.html" title="Immunosuppressive drug">Immunosuppressants</a></td>
</tr>
<tr>
<th style=""><a href="../../../r/e/p/Reproductive_system.html" title="Reproductive system">Reproductive system</a></th>
<td><a href="../../../h/o/r/Hormonal_contraception.html" title="Hormonal contraception">Hormonal contraception</a>, <a href="../../../f/e/r/Fertility_medication.html" title="Fertility medication">Fertility agents</a>, <a href="../../../s/e/l/Selective_estrogen_receptor_modulator.html" title="Selective estrogen receptor modulator">Selective estrogen receptor modulators</a></td>
</tr>
<tr>
<th style=""><a href="../../../s/k/i/Skin.html" title="Skin">Skin</a></th>
<td><a href="../../../a/n/t/Antipruritic.html" title="Antipruritic">Antipruritics</a></td>
</tr>
</table>

<!-- 
Pre-expand include size: 30065 bytes
Post-expand include size: 18190 bytes
Template argument size: 9795 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../b/e/t/Beta_blocker.html">http://en.wikipedia.org../../../b/e/t/Beta_blocker.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Category</a>: <span dir='ltr'><a href="../../../b/e/t/Category%7EBeta_blockers_59c7.html" title="Category:Beta blockers">Beta blockers</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../b/e/t/Beta_blocker.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../b/e/t/Talk%7EBeta_blocker_67ed.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Beta_blocker">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../de/b/e/t/Betablocker.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../fr/b/%C3%AA/t/B%C3%AAta-bloquant.html">Français</a>
	      </li>
	      	      <li>
	      <a href="../../../../nl/b/%C3%A8/t/B%C3%A8tablokker.html">Nederlands</a>
	      </li>
	      	      <li>
	      <a href="../../../../no/b/e/t/Betablokker.html">‪Norsk (bokmål)‬</a>
	      </li>
	      	      <li>
	      <a href="../../../../pl/l/e/k/Leki_beta-adrenolityczne.html">Polski</a>
	      </li>
	      	      <li>
	      <a href="../../../../pt/b/l/o/Bloqueador_beta_adren%C3%A9rgico.html">Português</a>
	      </li>
	      	      <li>
	      <a href="../../../../sv/b/e/t/Betablockerare.html">Svenska</a>
	      </li>
	      	      <li>
	      <a href="../../../../th/%E0%B9%80/%E0%B8%9A/%E0%B8%95/%E0%B9%80%E0%B8%9A%E0%B8%95%E0%B9%89%E0%B8%B2_%E0%B8%9A%E0%B8%A5%E0%B9%87%E0%B8%AD%E0%B8%81%E0%B9%80%E0%B8%81%E0%B8%AD%E0%B8%A3%E0%B9%8C.html">ไทย</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 21:47, 26 March 2007 by Wikipedia user <a href="../../../t/h/i/User%7EThijs%21bot_bdf4.html" title="User:Thijs!bot">Thijs!bot</a>. Based on work by Wikipedia user(s) <a href="../../../f/a/r/User%7EFarosdaughter_ce1a.html" title="User:Farosdaughter">Farosdaughter</a>, <a href="../../../l/a/m/User%7ELamaglama_f1a5.html" title="User:Lamaglama">Lamaglama</a>, Dcperi, <a href="../../../b/e/n/User%7EBenjaminevans82_7c6f.html" title="User:Benjaminevans82">Benjaminevans82</a>, <a href="../../../j/e/r/User%7EJerry_f493.html" title="User:Jerry">Jerry</a>, <a href="../../../c/h/r/User%7EChristopher_Parham_7957.html" title="User:Christopher Parham">Christopher Parham</a>, <a href="../../../m/i/k/User%7EMike6271_b1c8.html" title="User:Mike6271">Mike6271</a>, <a href="../../../e/d/_/User%7EEd_Fitzgerald_498b.html" title="User:Ed Fitzgerald">Ed Fitzgerald</a>, Eowyne, <a href="../../../n/b/a/User%7ENbauman_bc94.html" title="User:Nbauman">Nbauman</a>, <a href="../../../s/i/r/User%7ESir_Nicholas_de_Mimsy-Porpington_81f8.html" title="User:Sir Nicholas de Mimsy-Porpington">Sir Nicholas de Mimsy-Porpington</a>, Easterangel, Alexmuller, <a href="../../../n/e/d/User%7ENeddyseagoon_820c.html" title="User:Neddyseagoon">Neddyseagoon</a>, <a href="../../../m/a/n/User%7EManop_dd69.html" title="User:Manop">Manop</a>, <a href="../../../d/a/v/User%7EDavidruben_76a6.html" title="User:Davidruben">Davidruben</a>, <a href="../../../b/l/u/User%7EBluebot_e595.html" title="User:Bluebot">Bluebot</a>, <a href="../../../n/e/u/User%7ENeurophyre_f369.html" title="User:Neurophyre">Neurophyre</a>, <a href="../../../m/a/t/User%7EMats_Halldin_e04e.html" title="User:Mats Halldin">Mats Halldin</a>, <a href="../../../n/a/c/User%7ENaconkantari_d810.html" title="User:Naconkantari">Naconkantari</a>, <a href="../../../y/u/r/User%7EYurikBot_b393.html" title="User:YurikBot">YurikBot</a>, <a href="../../../t/m/o/User%7ETmopkisn_365a.html" title="User:Tmopkisn">Tmopkisn</a>, <a href="../../../t/a/w/User%7ETawkerbot4_5045.html" title="User:Tawkerbot4">Tawkerbot4</a>, <a href="../../../v/e/r/User%7EVerbalcontract_18d5.html" title="User:Verbalcontract">Verbalcontract</a>, <a href="../../../k/y/l/User%7EKylu_6ad3.html" title="User:Kylu">Kylu</a>, <a href="../../../w/i/n/User%7EWinick88_910f.html" title="User:Winick88">Winick88</a>, <a href="../../../t/e/c/User%7ETechelf_1565.html" title="User:Techelf">Techelf</a>, <a href="../../../e/t/h/User%7EEtherealmuse_6252.html" title="User:Etherealmuse">Etherealmuse</a>, <a href="../../../d/c/f/User%7EDcflyer_6887.html" title="User:Dcflyer">Dcflyer</a>, <a href="../../../s/i/l/User%7ESilverback_268b.html" title="User:Silverback">Silverback</a>, Townba, CHurst5841, <a href="../../../g/e/n/User%7EGene_Nygaard_634f.html" title="User:Gene Nygaard">Gene Nygaard</a>, <a href="../../../m/a/i/User%7EMais_oui%21_a53d.html" title="User:Mais oui!">Mais oui!</a>, <a href="../../../l/i/g/User%7ELight_current_29d4.html" title="User:Light current">Light current</a>, <a href="../../../j/i/m/User%7EJim_Butler_5a6c.html" title="User:Jim Butler">Jim Butler</a>, <a href="../../../a/n/i/User%7EAnimated_Cascade_c5c7.html" title="User:Animated Cascade">Animated Cascade</a>, <a href="../../../b/i/n/User%7EBinaryTed_aae0.html" title="User:BinaryTed">BinaryTed</a>, <a href="../../../t/s/a/User%7ETsalman_5545.html" title="User:Tsalman">Tsalman</a>, <a href="../../../a/n/d/User%7EAndrew73_a1aa.html" title="User:Andrew73">Andrew73</a>, <a href="../../../w/o/u/User%7EWouterstomp_b006.html" title="User:Wouterstomp">Wouterstomp</a>, <a href="../../../c/l/a/User%7EClawed_5038.html" title="User:Clawed">Clawed</a>, <a href="../../../t/o/y/User%7EToytoy_34ee.html" title="User:Toytoy">Toytoy</a>, <a href="../../../c/m/d/User%7ECmdrjameson_3c06.html" title="User:Cmdrjameson">Cmdrjameson</a>, <a href="../../../j/f/d/User%7EJfdwolff_9ea6.html" title="User:Jfdwolff">Jfdwolff</a>, <a href="../../../a/v/r/User%7EAvriette_f119.html" title="User:Avriette">Avriette</a>, <a href="../../../e/r/a/User%7EEras-mus_f9f9.html" title="User:Eras-mus">Eras-mus</a>, <a href="../../../e/d/w/User%7EEdward_42f0.html" title="User:Edward">Edward</a>, <a href="../../../a/x/l/User%7EAxl_2118.html" title="User:Axl">Axl</a>, <a href="../../../p/a/k/User%7EPakaran_a4a0.html" title="User:Pakaran">Pakaran</a>, <a href="../../../k/p/j/User%7EKpjas_9cb5.html" title="User:Kpjas">Kpjas</a>, <a href="../../../s/a/r/User%7ESarge_Baldy_6bdd.html" title="User:Sarge Baldy">Sarge Baldy</a>, <a href="../../../m/a/t/User%7EMattKingston_4e5c.html" title="User:MattKingston">MattKingston</a>, <a href="../../../e/e/q/User%7EEequor_b13d.html" title="User:Eequor">Eequor</a>, <a href="../../../k/s/h/User%7EKsheka_e2cf.html" title="User:Ksheka">Ksheka</a>, <a href="../../../p/a/t/User%7EPatrick_7b47.html" title="User:Patrick">Patrick</a>, <a href="../../../u/g/e/User%7EUgen64_718c.html" title="User:Ugen64">Ugen64</a>, <a href="../../../p/i/t/User%7EPit_aba8.html" title="User:Pit">Pit</a>, <a href="../../../g/g/a/User%7EGGano_e118.html" title="User:GGano">GGano</a> and <a href="../../../a/x/e/User%7EAxelBoldt_4306.html" title="User:AxelBoldt">AxelBoldt</a> and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
